CGM access, AID affordability, healthcare advocacy and diabetes policy education.
News Analysis · By Philip Hall · Published 20 July 2026 Recent reporting by 60 Minutes, The Sydney Morning Herald and The Age, including the 60 Minutes investigation “Help That Harms”, raised legitimate concerns about medical-device safety. The accompanying article published by The Age and The Sydney Morning Herald provided important clinical context, including comments … Read more
Analysis of the Cost of Inaction report, the 350,000 Australians excluded from subsidised CGM, and the evidence base for expanding diabetes technology access.
Australia is spending more than $110 million a year on potentially avoidable diabetes hospital costs while an estimated 350,000 people remain locked out of subsidised CGM technology. The 2024 Parliamentary Inquiry recommended expanding access. The 2026 Federal Budget did not fund that expansion.
A practical, non-partisan guide to advocating for fairer Automated Insulin Delivery access in Australia. Three levels of action, what to ask for and how to make your voice heard.
Managing the cost of Type 1 diabetes in Australia. Practical guidance on NDSS subsidies, state funding, insurance and reducing out-of-pocket expenses.
